Modified viral vectors for disease treatment
“We are committed to a reality: healing”.
With these words, Juan Carlos Ramírez, Chief Scientific Officer at VIVEbiotech, described the company’s work during an interview on the program La Ventana on SER radio.
As he explained, “we produce genetically modified viruses that act as carriers of genes which are defective in many diseases.” He also noted that these therapies can help address a wide range of illnesses: anemias, blood cancers, hemophilia, thalassemia, and more.